261 related articles for article (PubMed ID: 15900617)
1. Pharmacokinetics and tissue distribution of d-alpha-tocopheryl succinate formulations following intravenous administration in the rat.
Teng XW; Davies NM; Fukuda C; Good RL; Fariss MW
Biopharm Drug Dispos; 2005 Jul; 26(5):195-203. PubMed ID: 15900617
[TBL] [Abstract][Full Text] [Related]
2. Formulation dependent pharmacokinetics, bioavailability and renal toxicity of a selective cyclooxygenase-1 inhibitor SC-560 in the rat.
Teng XW; Abu-Mellal AK; Davies NM
J Pharm Pharm Sci; 2003; 6(2):205-10. PubMed ID: 12935431
[TBL] [Abstract][Full Text] [Related]
3. Role of cellular energy status in tocopheryl hemisuccinate cytoprotection against ethyl methanesulfonate-induced toxicity.
Ray SD; Fariss MW
Arch Biochem Biophys; 1994 May; 311(1):180-90. PubMed ID: 8185315
[TBL] [Abstract][Full Text] [Related]
4. Direct high-performance liquid chromatographic analysis of D-tocopheryl acid succinate and derivatives.
Good RL; Roupe KA; Fukuda C; Clifton GD; Fariss MW; Davies NM
J Pharm Biomed Anal; 2005 Sep; 39(1-2):33-8. PubMed ID: 16085132
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
6. NTP toxicology and carcinogenesis studies of 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (CAS No. 57465-28-8) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Jan; (520):4-246. PubMed ID: 16628245
[TBL] [Abstract][Full Text] [Related]
7. Comparison of pharmacokinetics of M1, M2, M3, and M4 after intravenous administration of DA-125 or ME2303 to mice and rats. New adriamycin analogues containing fluorine.
Yoon EJ; Lee WI; Shim HJ; Lee SD; Kim WB; Yang J; Lee MG
Biopharm Drug Dispos; 1996 Jul; 17(5):373-420. PubMed ID: 8830976
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of difloxacin in pigs and broilers following intravenous, intramuscular, and oral single-dose applications.
Ding HZ; Yang GX; Huang XH; Chen ZL; Zeng ZL
J Vet Pharmacol Ther; 2008 Jun; 31(3):200-4. PubMed ID: 18471140
[TBL] [Abstract][Full Text] [Related]
10. D-α-tocopheryl polyethylene glycol 1000 succinate-containing vehicles provide no detectable chemoprotection from oxidative damage.
Baumgart BR; Van Vleet TR; Simic D; Salcedo TW; Lentz K; Donegan M; Davies MH; Bunch RT; Sanderson TP; Lange RW
J Appl Toxicol; 2015 Jul; 35(7):791-8. PubMed ID: 25348750
[TBL] [Abstract][Full Text] [Related]
11. The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.
Brown SA; Boucher JF; Hubbard VL; Prough MJ; Flook TF
J Vet Pharmacol Ther; 2007 Aug; 30(4):320-6. PubMed ID: 17610405
[TBL] [Abstract][Full Text] [Related]
12. The selective antiproliferative effects of alpha-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia cells result from the action of the intact compounds.
Fariss MW; Fortuna MB; Everett CK; Smith JD; Trent DF; Djuric Z
Cancer Res; 1994 Jul; 54(13):3346-51. PubMed ID: 8012947
[TBL] [Abstract][Full Text] [Related]
13. Multi-targeted antifolate (MTA): pharmacokinetics of intraperitoneal administration in a rat model.
Pestieau SR; Stuart OA; Sugarbaker PH
Eur J Surg Oncol; 2000 Nov; 26(7):696-700. PubMed ID: 11078617
[TBL] [Abstract][Full Text] [Related]
14. Effect of formulation on the delivery and metabolism of alpha-tocopheryl acetate.
Rangarajan M; Zatz JL
J Cosmet Sci; 2001; 52(4):225-36. PubMed ID: 11479655
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of guanosine in rats following intravenous or intramuscular administration of a 1:1 mixture of guanosine and acriflavine, a potential antitumor agent.
Shin DH; Choi KS; Cho BS; Song S; Moon DC; Hong JT; Lee CK; Chung YB
Arch Pharm Res; 2008 Oct; 31(10):1347-53. PubMed ID: 18958427
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and lung tissue concentrations of tulathromycin in swine.
Benchaoui HA; Nowakowski M; Sherington J; Rowan TG; Sunderland SJ
J Vet Pharmacol Ther; 2004 Aug; 27(4):203-10. PubMed ID: 15305848
[TBL] [Abstract][Full Text] [Related]
17. Direct comparison of two pegylated liposomal doxorubicin formulations: is AUC predictive for toxicity and efficacy?
Cui J; Li C; Guo W; Li Y; Wang C; Zhang L; Zhang L; Hao Y; Wang Y
J Control Release; 2007 Apr; 118(2):204-15. PubMed ID: 17239468
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and biodistribution of the camptothecin-polymer conjugate IT-101 in rats and tumor-bearing mice.
Schluep T; Cheng J; Khin KT; Davis ME
Cancer Chemother Pharmacol; 2006 May; 57(5):654-62. PubMed ID: 16133526
[TBL] [Abstract][Full Text] [Related]
19. Formulation-dependent toxicokinetics explains differences in the GI absorption, bioavailability and acute neurotoxicity of deltamethrin in rats.
Kim KB; Anand SS; Muralidhara S; Kim HJ; Bruckner JV
Toxicology; 2007 May; 234(3):194-202. PubMed ID: 17448586
[TBL] [Abstract][Full Text] [Related]
20. Vitamin E kinetics after intraperitoneal administration of DL-alpha-tocopherol and DL-alpha-tocopherol acetate in sheep.
Toutain PL; Laurentie MP; Hidiroglou N; Hidiroglou M
Ann Rech Vet; 1992; 23(2):117-30. PubMed ID: 1610075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
